ASH 51st (2009)

Drupal spam blocked by CleanTalk.
Title Content type
Antifungal Prophylaxis (AFP) for Patients (Pts) with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Undergoing Intensive Chemotherapy: An Experience with 730 Pts. (click for details)
Baseline Serum Ferritin Predicts Rate of Infection in Patients with Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome. (click for details)
Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival. (click for details)
Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography. (click for details)
Four Drugs Induction Therapy (fludarabine, cytarabine, idarubicin and gemtuzumab ozogamycin) for the Treatment of Elderly Acute Myeloid Leukemia Patients. (click for details)
Influenza A H1N1 Virus Infection in Two Hematopoietic Stem Cell Transplant Recipients. (click for details)
HHV-6 Encephalitis in Pediatric Unrelated Umbilical Cord Blood Transplantation: Role for Ganciclovir Prophylaxis? (click for details)
Pulmonary Infection After Allo-Transplantation: Fungus or Tuberculosis? 2 Case Report. (click for details)
Life-Threatening Complications Suspected Due to Clinical Pharmacokinetic Interaction Between Cyclosporine A and Triazole Antifungal Agents in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Recipients. (click for details)
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study). (click for details)

Pages

Subscribe to ASH 51st (2009)